Serological Heavy Metal Assessment in Persons with IBD

BACKGROUND: Emerging evidence implicates heavy metals (HM) as environmental factors which may influence Crohn's disease (CD) and ulcerative colitis (UC) pathogenesis. METHODS: The present report includes two related studies. The first ('serum-only') compares HM serum levels (parts per billion, ppb) in people with CD and UC, including aluminum (Al), chromium (Cr), mercury (Hg), and titanium (Ti) compared to people with multiple sclerosis (MS) and healthy controls (HC). The second study correlated serum and tissue levels of HM in 18 persons undergoing colonoscopy and biopsy. Serum and intestinal biopsies of Al, Cr, Ti, and Hg concentrations were quantified using inductively coupled plasma mass spectrometry for both studies. RESULTS: The serum-only study included 287 participants (CD (n=100), UC (n=50), MS (n=49), and HC (n= 88)). Versus HC, adjusted serum Al concentrations were higher in CD [fold change, 1.34; 95%CI (1.12-1.61)], lower in UC [0.64; 95%CI (0.51-0.80)], and lower in MS [0.76; 95%CI (0.60-0.97)]. Ti concentrations were lower in all three disease groups versus HC. Cr concentrations, higher in MS [2.34; 95% CI (1.59-3.45)], did not differ significantly between HC and either CD or UC. Hg concentrations were higher in both CD [2.17; 95%CI (1.52-3.09) and MS [1.62; 95%CI (1.02-2.59)]. In our small exploratory substudy, we found no statistically significant correlation between serum and intestinal tissue HM levels. CONCLUSION: Our report demonstrates differences in serum HM levels in people with CD relative to persons with UC or HC. Future research will benefit from the evaluation of these disparities and identification of potential implicated mechanisms.

Authors

Institutions

Publication Details

Journal
Clinical and Translational Gastroenterology
Published
2026-11-12
DOI
https://doi.org/10.14309/ctg.0000000000001123
Primary Topic
Inflammatory Bowel Disease
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Serological Heavy Metal Assessment in Persons with IBD

Heather Armstrong, Charles Noah Bernstein, Carol Ann Hitchon, Jean‐Eric Ghia et al.
Clinical and Translational Gastroenterology
Inflammatory Bowel Disease
article

Serological Heavy Metal Assessment in Persons with IBD

Heather Armstrong, Charles Noah Bernstein, Carol Ann Hitchon, Jean‐Eric Ghia, Ruth Ann Marrie, Samuel Narvey, Casandra Dolovich
article en

Abstract

BACKGROUND: Emerging evidence implicates heavy metals (HM) as environmental factors which may influence Crohn's disease (CD) and ulcerative colitis (UC) pathogenesis. METHODS: The present report includes two related studies. The first ('serum-only') compares HM serum levels (parts per billion, ppb) in people with CD and UC, including aluminum (Al), chromium (Cr), mercury (Hg), and titanium (Ti) compared to people with multiple sclerosis (MS) and healthy controls (HC). The second study correlated serum and tissue levels of HM in 18 persons undergoing colonoscopy and biopsy. Serum and intestinal biopsies of Al, Cr, Ti, and Hg concentrations were quantified using inductively coupled plasma mass spectrometry for both studies. RESULTS: The serum-only study included 287 participants (CD (n=100), UC (n=50), MS (n=49), and HC (n= 88)). Versus HC, adjusted serum Al concentrations were higher in CD [fold change, 1.34; 95%CI (1.12-1.61)], lower in UC [0.64; 95%CI (0.51-0.80)], and lower in MS [0.76; 95%CI (0.60-0.97)]. Ti concentrations were lower in all three disease groups versus HC. Cr concentrations, higher in MS [2.34; 95% CI (1.59-3.45)], did not differ significantly between HC and either CD or UC. Hg concentrations were higher in both CD [2.17; 95%CI (1.52-3.09) and MS [1.62; 95%CI (1.02-2.59)]. In our small exploratory substudy, we found no statistically significant correlation between serum and intestinal tissue HM levels. CONCLUSION: Our report demonstrates differences in serum HM levels in people with CD relative to persons with UC or HC. Future research will benefit from the evaluation of these disparities and identification of potential implicated mechanisms.

Clinical and Translational Gastroenterology
Dalhousie University (CA), University of Alberta (CA), University of Manitoba (CA)
Good health and well-being
Inflammatory Bowel Disease
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon